| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Oct 26, 2021 | Sell(S) | 278 | $7.90 | $2K | 0 |
| Oct 25, 2021 | Grant(A) | 129 | $7.78 | $1K | 278 |
| Oct 18, 2021 | Grant(A) | 2K | $10.10 | $25K | 2K |
| Sep 29, 2021 | Grant(A) | 10 | $10.08 | $101 | 15 |
| Sep 28, 2021 | Grant(A) | 5 | $10.07 | $50 | 5 |
| Sep 28, 2021 | Grant(A) | 149 | $10.08 | $2K | 149 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-028917) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for SAB Biotherapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.